FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308183025> ?p ?o ?g. }

• W4308183025 endingPage "204062072211323" @default.
• W4308183025 startingPage "204062072211323" @default.
• W4308183025 abstract "Background: The clinical risk classification of acute myelocytic leukemia (AML) is largely based on cytogenetic and molecular genetic detection. However, the optimal treatment for intermediate-risk AML patients remains uncertain. Further refinement and improvement of prognostic stratification are therefore necessary. Objectives: The aim of this study was to identify serum protein biomarkers to refine risk stratification in AML patients. Design: This study is a retrospective study. Methods: Label-free proteomics was used to identify the differential abundance of serum proteins in AML patients. Transcriptomic data were combined to identify key altered markers that could indicate the risk rank of AML patients. The survival status was assessed by Kaplan–Meier and multivariate Cox regression analyses. Results: We delineated serum protein expression in a population of AML patients. Many biological processes were influenced by the identified differentially expressed proteins. Association analysis of transcriptome data showed that intercellular adhesion molecule-2 (ICAM2) had a higher survival prediction value in the intermediate-risk AML group. ICAM2 was detrimental for intermediate-risk AML, regardless of whether patients received bone marrow transplantation. ICAM2 well distinguishes the intermediate group of patients, whose probability of survival is comparable to that of patients with the ELN-2017 according to the reference classification. In addition, newly established stratified clinical features were associated with leukemia stem cell scores. Conclusion: The inclusion of ICAM2 expression into the AML risk classification according to ELN-2017 was a good way to transfer patients from three to two groups. Thus, providing more information for clinical decision-making to improve intermediate-risk stratification in AML patients." @default.
• W4308183025 created "2022-11-09" @default.
• W4308183025 creator A5001882175 @default.
• W4308183025 creator A5004349988 @default.
• W4308183025 creator A5009318195 @default.
• W4308183025 creator A5011948525 @default.
• W4308183025 creator A5019340524 @default.
• W4308183025 creator A5046225712 @default.
• W4308183025 creator A5063344004 @default.
• W4308183025 creator A5064449808 @default.
• W4308183025 creator A5077284155 @default.
• W4308183025 date "2022-01-01" @default.
• W4308183025 modified "2023-10-14" @default.
• W4308183025 title "Serum proteomics screening intercellular adhesion molecule-2 improves intermediate-risk stratification in acute myeloid leukemia" @default.
• W4308183025 cites W1931312556 @default.
• W4308183025 cites W193461371 @default.
• W4308183025 cites W1994041743 @default.
• W4308183025 cites W2020722780 @default.
• W4308183025 cites W2052926478 @default.
• W4308183025 cites W2074449268 @default.
• W4308183025 cites W2091854488 @default.
• W4308183025 cites W2097126423 @default.
• W4308183025 cites W2107396952 @default.
• W4308183025 cites W2108750263 @default.
• W4308183025 cites W2116298760 @default.
• W4308183025 cites W2116858301 @default.
• W4308183025 cites W2127979139 @default.
• W4308183025 cites W2275737843 @default.
• W4308183025 cites W2325815501 @default.
• W4308183025 cites W2339658711 @default.
• W4308183025 cites W2471743272 @default.
• W4308183025 cites W2510271288 @default.
• W4308183025 cites W2560012305 @default.
• W4308183025 cites W2591153485 @default.
• W4308183025 cites W2808678267 @default.
• W4308183025 cites W2967991154 @default.
• W4308183025 cites W2999695559 @default.
• W4308183025 cites W3013699398 @default.
• W4308183025 cites W3028877880 @default.
• W4308183025 cites W3041808241 @default.
• W4308183025 cites W3045364226 @default.
• W4308183025 cites W3085209778 @default.
• W4308183025 cites W3092924054 @default.
• W4308183025 cites W3115529772 @default.
• W4308183025 cites W3119843276 @default.
• W4308183025 cites W3147098608 @default.
• W4308183025 cites W3179502409 @default.
• W4308183025 cites W3206209622 @default.
• W4308183025 cites W3214072874 @default.
• W4308183025 cites W4200231149 @default.
• W4308183025 cites W4205131504 @default.
• W4308183025 cites W4206001130 @default.
• W4308183025 cites W4206658968 @default.
• W4308183025 cites W4207041226 @default.
• W4308183025 cites W4213373251 @default.
• W4308183025 cites W4214778022 @default.
• W4308183025 cites W4214843261 @default.
• W4308183025 cites W4283835235 @default.
• W4308183025 doi "https://doi.org/10.1177/20406207221132346" @default.
• W4308183025 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36324489" @default.
• W4308183025 hasPublicationYear "2022" @default.
• W4308183025 type Work @default.
• W4308183025 citedByCount "3" @default.
• W4308183025 countsByYear W43081830252023 @default.
• W4308183025 crossrefType "journal-article" @default.
• W4308183025 hasAuthorship W4308183025A5001882175 @default.
• W4308183025 hasAuthorship W4308183025A5004349988 @default.
• W4308183025 hasAuthorship W4308183025A5009318195 @default.
• W4308183025 hasAuthorship W4308183025A5011948525 @default.
• W4308183025 hasAuthorship W4308183025A5019340524 @default.
• W4308183025 hasAuthorship W4308183025A5046225712 @default.
• W4308183025 hasAuthorship W4308183025A5063344004 @default.
• W4308183025 hasAuthorship W4308183025A5064449808 @default.
• W4308183025 hasAuthorship W4308183025A5077284155 @default.
• W4308183025 hasBestOaLocation W43081830251 @default.
• W4308183025 hasConcept C126322002 @default.
• W4308183025 hasConcept C143998085 @default.
• W4308183025 hasConcept C2778461978 @default.
• W4308183025 hasConcept C2778729363 @default.
• W4308183025 hasConcept C2908647359 @default.
• W4308183025 hasConcept C50382708 @default.
• W4308183025 hasConcept C60644358 @default.
• W4308183025 hasConcept C71924100 @default.
• W4308183025 hasConcept C86803240 @default.
• W4308183025 hasConcept C99454951 @default.
• W4308183025 hasConceptScore W4308183025C126322002 @default.
• W4308183025 hasConceptScore W4308183025C143998085 @default.
• W4308183025 hasConceptScore W4308183025C2778461978 @default.
• W4308183025 hasConceptScore W4308183025C2778729363 @default.
• W4308183025 hasConceptScore W4308183025C2908647359 @default.
• W4308183025 hasConceptScore W4308183025C50382708 @default.
• W4308183025 hasConceptScore W4308183025C60644358 @default.
• W4308183025 hasConceptScore W4308183025C71924100 @default.
• W4308183025 hasConceptScore W4308183025C86803240 @default.
• W4308183025 hasConceptScore W4308183025C99454951 @default.
• W4308183025 hasFunder F4320321001 @default.
• W4308183025 hasFunder F4320329542 @default.
• W4308183025 hasLocation W43081830251 @default.

• next